期刊
MUSCLE & NERVE
卷 38, 期 4, 页码 1236-1245出版社
WILEY
DOI: 10.1002/mus.21025
关键词
Pompe disease; glycogen storage disease type II; acid maltase deficiency; outcome measures; prospective cohort study
资金
- Genzyme Corp., Cambridge, MA
- National Center for Research Resources (NCRR) [M01-RR-00037]
The objective of this 12-month study was to describe the clinical features of late-onset Pompe disease and identify appropriate outcome measures for use in clinical trials. Assessments included quantitative muscle testing (QMT), functional activities (FAA), 6-min walk test (6MWT), and pulmonary function testing (PFT). Percent predicted values indicated quantifiable upper and lower extremity weakness, impaired walking ability, and respiratory muscle weakness. Significant declines in arm and leg strength and pulmonary function were observed during the study period. The outcome measures were demonstrated to be safe and reliable. Symptom duration was identified as the best predictor of the extent of skeletal and respiratory muscle weakness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据